Literature DB >> 21940576

Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT?

Ingrid Millet1, Fernanda Curros Doyon, Denis Hoa, Rodolphe Thuret, Samuel Merigeaud, Isabelle Serre, Patrice Taourel.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the diagnostic performance of CT in determining whether a small solid renal enhancing mass is benign or malignant.
MATERIALS AND METHODS: Ninety-nine biopsies of enhancing solid renal masses 4 cm or smaller without fat on CT scans were performed under CT fluoroscopic guidance. The growth pattern, interface with parenchyma, presence of a scar and segmental inversion enhancement, unenhanced CT histogram, and pattern and degree of enhancement on triphasic MDCT images were independently evaluated by two radiologists. Biopsy and pathology reports were used as the reference standard, and imaging follow-up of benign lesions was performed for at least 1 year. Statistical analysis was performed to determine the significance of CT criteria in differentiating malignant from benign lesions.
RESULTS: Of the 99 lesions, 74 (75%) were malignant at biopsy, and 25 (25%) were benign. Lesions with gradual enhancement were more likely to be benign. No significant correlation was found between other CT features and a malignant or benign diagnosis. The sensitivity, specificity, and positive and negative predictive values of progressive enhancement for a diagnosis of benignity were 60%, 73%, 43%, and 84%.
CONCLUSION: In the evaluation of enhancing small solid renal lesions without fat, no CT criteria were of substantial help in differentiating malignant from benign lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940576     DOI: 10.2214/AJR.10.6276

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  31 in total

1.  Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).

Authors:  Nicola Schieda; Maali Al-Subhi; Trevor A Flood; Mohammed El-Khodary; Matthew D F McInnes
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

2.  Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.

Authors:  Amjad Shalabi; Zaid Abassi; Hoda Awad; Sarel Halachmi; Boaz Moskovitz; Yoram Kluger; Ofer Nativ
Journal:  World J Urol       Date:  2013-02-22       Impact factor: 4.226

3.  Renal cell carcinomas with t(6;11) (p21;q12): presentation of two cases with computed tomography findings.

Authors:  YiJun Zhao; Jin Yao; Ni Chen; Hao Zeng; Wei Zhang
Journal:  Jpn J Radiol       Date:  2015-05-07       Impact factor: 2.374

Review 4.  Imaging Protocols for Active Surveillance in Renal Cell Carcinoma.

Authors:  Christine W Liaw; Jared S Winoker; Reza Mehrazin
Journal:  Curr Urol Rep       Date:  2018-08-13       Impact factor: 3.092

Review 5.  Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review.

Authors:  Nicola Schieda; Matthew D F McInnes; Lilly Cao
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

Review 6.  The role of imaging in the active surveillance of small renal masses.

Authors:  P G K Wagstaff; P J Zondervan; J J M C H de la Rosette; M P Laguna
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

7.  Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy.

Authors:  Masatomo Nishikawa; Hideaki Miyake; Kazuhiro Kitajima; Satoru Takahashi; Kazuro Sugimura; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2014-02-15       Impact factor: 3.402

8.  Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-02-21       Impact factor: 5.315

9.  Distinguishing enhancing from nonenhancing renal masses with dual-source dual-energy CT: iodine quantification versus standard enhancement measurements.

Authors:  Giorgio Ascenti; Achille Mileto; Bernhard Krauss; Michele Gaeta; Alfredo Blandino; Emanuele Scribano; Nicola Settineri; Silvio Mazziotti
Journal:  Eur Radiol       Date:  2013-03-12       Impact factor: 5.315

10.  Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas.

Authors:  Kayvan R Keshari; Renuka Sriram; Bertram L Koelsch; Mark Van Criekinge; David M Wilson; John Kurhanewicz; Zhen J Wang
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.